Abstract:-related disorders encompass a range of neurodevelopmental and epilepsy phenotypes. However, despite representing one of the most common epilepsy-associated channelopathies, the longitudinal progression of its clinical features remains largely uncharacterized. Here, we harmonized electronic medical record data of 82 individuals with -related disorders. Clinical data was mapped to the standardized language of the Human Phenotype Ontology to reconstruct the natural history of -related disorders in comparison to a cohort of 2,833 individuals with known or presumed genetic epilepsies. Compared to other known or presumed genetic epilepsies, those with -related disorders had earlier generalized seizures, including a ten-fold risk for generalized-onset seizures at 9 months ( = 4.98 x 10 , OR 10.65, CI 6.07-18.77) and >40-fold risk bilateral tonic-clonic seizures at 1 year ( = 1.76 x 10 , OR 46.09, CI 10.72-275.01). Individuals carrying gain-of-function variants had particularly high generalized seizure risk at 9 months ( = 0.005, OR 3.85, CI 1.35-11.55), as well as an increased risk for global developmental delay as early as 3 months ( = 0.002, OR 5.67, CI 1.74-20.23) when compared to the broader cohort. Individuals with loss-of-function variants were more likely to experience absence seizures, most prominently at 4.25 years ( = 0.013, OR 32.71, CI 1.44-2193.51). Compared to the wider cohort, individuals with the recurrent p.Arg850Gln variant were more likely to have infantile spasms at 6 months ( = 0.016, OR 12.02, CI 1.20-164.23), those with variants at the p.Arg1872Trp/Gln/Leu hotspot were more likely to have neonatal seizures ( = 0.025, OR 16.84, CI 0.99-291.58). Individuals with the recurrent p.Gly1475Arg variant were more likely to have active epilepsy after 5 years of age. Focal seizures in later childhood were more prominent in individuals with the recurrent p.Arg1617Gln variant. -related disorders distinguish themselves from other genetic epilepsies by the frequent generalized-onset seizures in infancy, prominent early epileptic and developmental features in gain-of-function variant carriers, and unique seizure phenotypes in those with recurrent variants. Our study provides a longitudinal perspective on this genetic condition, paving the way for the future precision medicine approaches.

A Longitudinal Exploration of CACNA1A-related Hemiplegic Migraine in Children

"Living with" CACNA1A-related hemiplegic migraine, a disease concept model

Two pediatric patients with hemiplegic migraine presenting as acute encephalopathy: case reports and a literature review

Natural history of non-polyglutamine CACNA1A disease in Austria

Extended spectrum of idiopathic generalized epilepsies associated with CACNA1H functional variants

AARS and CACNA1A mutations: diagnostic insights into a case report of uncommon epileptic encephalopathy phenotypes in two siblings

Variable manifestations of familial hemiplegic migraine associated with reversible cerebral edema in children

Seizure and movement disorder in CACNA1E developmental and epileptic encephalopathy: Two sides of the same coin or same side of two different coins?

Deciphering the dynamic clinical patterns in -related disorders using real-world data

Biallelic CACNA1A variants: Review of literature and report of a child with drug‐resistant epilepsy and developmental delay

The R900S Mutation in CACNA1S Associated with Hypokalemic Periodic Paralysis

Familial hemiplegic migraine in Indian children—a tertiary center experience

Treatment of CACNA1A Encephalopathy and Cerebral Edema with Magnesium and Dexamethasone

Genotype-phenotype Correlation of CACNA1A Variants in Children with Epilepsy.

KCNT1-related epilepsy: An international multicenter cohort of 27 pediatric cases

Functional Characterization and Neuronal Modeling of the Effects of Childhood Absence Epilepsy Variants of CACNA1H, a T-type Calcium Channel.

SCN1A-Related Epilepsy: Novel Mutations and Rare Phenotypes

The Genotype and Phenotype of CACNA1A Variants Related Developmental and Epileptic Encephalopathy Chinese Full Text

Case Report: A Novel CACNA1A Mutation Caused Flunarizine-Responsive Type 2 Episodic Ataxia and Hemiplegic Migraine With Abnormal MRI of Cerebral White Matter

SCN1A‐related phenotypes: Epilepsy and beyond

Analyzing Clinical and Genetic Characteristics of a Cohort with Multiple Congenital Anomalies-Hypotonia-seizures Syndrome (MCAHS)